Edward Stelmakh - Net Worth and Insider Trading

Edward Stelmakh Net Worth

The estimated net worth of Edward Stelmakh is at least $36,900 dollars as of 2024-05-24. Edward Stelmakh is the CFO/COO of OptimizeRx Corp and owns about 3,000 shares of OptimizeRx Corp (OPRX) stock worth over $36,900. Details can be seen in Edward Stelmakh's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Edward Stelmakh has not made any transactions after 2022-08-15 and currently still holds the listed stock(s).

Transaction Summary of Edward Stelmakh

To

Edward Stelmakh Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Edward Stelmakh owns 1 companies in total, including OptimizeRx Corp (OPRX) .

Click here to see the complete history of Edward Stelmakh’s form 4 insider trades.

Insider Ownership Summary of Edward Stelmakh

Ticker Comapny Transaction Date Type of Owner
OPRX OptimizeRx Corp 2022-08-15 COO and CFO

Edward Stelmakh Latest Holdings Summary

Edward Stelmakh currently owns a total of 1 stock. Edward Stelmakh owns 3,000 shares of OptimizeRx Corp (OPRX) as of August 15, 2022, with a value of $36,900.

Latest Holdings of Edward Stelmakh

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
OPRX OptimizeRx Corp 2022-08-15 3,000 12.30 36,900

Holding Weightings of Edward Stelmakh


Edward Stelmakh Form 4 Trading Tracker

According to the SEC Form 4 filings, Edward Stelmakh has made a total of 1 transactions in OptimizeRx Corp (OPRX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in OptimizeRx Corp is the acquisition of 3,000 shares on August 15, 2022, which cost Edward Stelmakh around $46,290.

Insider Trading History of Edward Stelmakh

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Edward Stelmakh Trading Performance

GuruFocus tracks the stock performance after each of Edward Stelmakh's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Edward Stelmakh is 41.28%. GuruFocus also compares Edward Stelmakh's trading performance to market benchmark return within the same time period. The performance of stocks bought by Edward Stelmakh within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Edward Stelmakh's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Edward Stelmakh

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -0.13
Relative Return to S&P 500(%) 9.08

Edward Stelmakh Ownership Network

Ownership Network List of Edward Stelmakh

No Data

Ownership Network Relation of Edward Stelmakh


Edward Stelmakh Owned Company Details

What does OptimizeRx Corp do?

Who are the key executives at OptimizeRx Corp?

Edward Stelmakh is the COO and CFO of OptimizeRx Corp. Other key executives at OptimizeRx Corp include General Counsel and CCO Marion Odence-ford , Chief Commercial Officer Theresa Greco , and Chief Product Officer Doug Besch .

OptimizeRx Corp (OPRX) Insider Trades Summary

Over the past 18 months, Edward Stelmakh made no insider transaction in OptimizeRx Corp (OPRX). Other recent insider transactions involving OptimizeRx Corp (OPRX) include a net sale of 4,000 shares made by Marion Odence-ford ,

In summary, during the past 3 months, insiders sold 0 shares of OptimizeRx Corp (OPRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 4,000 shares of OptimizeRx Corp (OPRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 4,000 shares.

OptimizeRx Corp (OPRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

OptimizeRx Corp Insider Transactions

No Available Data

Edward Stelmakh Mailing Address

Above is the net worth, insider trading, and ownership report for Edward Stelmakh. You might contact Edward Stelmakh via mailing address: 400 Water Street, Suite 200, Rochester Mi 48307.

Discussions on Edward Stelmakh

No discussions yet.